| Ticker Details |
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
|
| IPO Date: |
July 11, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$15.26B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.92 | 1.96%
|
| Avg Daily Range (30 D): |
$4.77 | 2.04%
|
| Avg Daily Range (90 D): |
$4.55 | 2.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.17M |
| Avg Daily Volume (30 D): |
.63M |
| Avg Daily Volume (90 D): |
.61M |
| Trade Size |
| Avg Trade Size (Sh.): |
66 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Institutional Trades: |
4,222 |
| Avg Institutional Trade: |
$4M |
| Avg Institutional Trade (30 D): |
$12.24M |
| Avg Institutional Trade (90 D): |
$8.51M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.13M |
| Avg Closing Trade (30 D): |
$10.88M |
| Avg Closing Trade (90 D): |
$9.29M |
| Avg Closing Volume: |
27.25K |
|
|
|
|
|
